(CMP) Compass Minerals - Ratings and Ratios
Salt, Fertilizer, Deicer, Sulfate Of Potash, Magnesium Chloride
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 58.0% |
| Value at Risk 5%th | 87.7% |
| Relative Tail Risk | -8.06% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.37 |
| Alpha | 77.66 |
| CAGR/Max DD | -0.25 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.391 |
| Beta | 0.571 |
| Beta Downside | 0.143 |
| Drawdowns 3y | |
|---|---|
| Max DD | 83.27% |
| Mean DD | 54.72% |
| Median DD | 58.56% |
Description: CMP Compass Minerals December 01, 2025
Compass Minerals International Inc. (NYSE:CMP) is a diversified mineral producer operating two primary segments: Salt and Plant Nutrition. The Salt segment manufactures and markets sodium chloride, magnesium chloride, and related blends for road deicing, water treatment, and industrial uses, while the Plant Nutrition segment sells the Protassium+ line of sulfate-of-potash fertilizers, turf products, and magnesium-chloride fire retardants to agricultural distributors and growers.
In FY 2023 the company reported revenue of roughly $2.1 billion, with the Salt segment contributing about 55 % of sales and delivering an operating margin near 16 %, whereas Plant Nutrition generated the remaining 45 % with a slightly lower margin (~13 %). CMP maintains a dividend yield around 2.5 % and a net debt-to-EBITDA ratio of 2.2×, indicating moderate leverage relative to peers in the diversified metals & mining sub-industry.
Key economic drivers include (1) winter weather severity, which directly influences deicing salt demand and can cause revenue swings of ±10 % year-over-year; (2) U.S. corn and soybean planting acreage, a leading determinant of sulfate-of-potash consumption, where a 1 % change in planted acres historically moves Plant Nutrition sales by roughly 0.5 %; and (3) global commodity price cycles for potassium and magnesium salts, which affect both input costs and pricing power. A colder-than-average winter or a surge in agricultural planting could materially boost CMP’s top line, while milder weather or a downturn in crop prices would have the opposite effect.
For a deeper dive into CMP’s valuation metrics and peer comparison, you might explore the analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (-79.8m TTM) > 0 and > 6% of Revenue (6% = 74.6m TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA 23.37pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 24.65% (prev 37.52%; Δ -12.87pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.13 (>3.0%) and CFO 197.7m > Net Income -79.8m (YES >=105%, WARN >=100%) |
| Net Debt (841.9m) to EBITDA (118.0m) ratio: 7.13 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.15 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (42.0m) change vs 12m ago 1.57% (target <= -2.0% for YES) |
| Gross Margin 15.33% (prev 16.95%; Δ -1.62pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 78.32% (prev 60.18%; Δ 18.14pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.22 (EBITDA TTM 118.0m / Interest Expense TTM 68.5m) >= 6 (WARN >= 3) |
Altman Z'' 1.06
| (A) 0.20 = (Total Current Assets 572.2m - Total Current Liabilities 265.6m) / Total Assets 1.54b |
| (B) -0.05 = Retained Earnings (Balance) -77.6m / Total Assets 1.54b |
| (C) 0.01 = EBIT TTM 14.8m / Avg Total Assets 1.59b |
| (D) -0.14 = Book Value of Equity -185.1m / Total Liabilities 1.30b |
| Total Rating: 1.06 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 43.61
| 1. Piotroski 4.50pt |
| 2. FCF Yield 7.70% |
| 3. FCF Margin 10.29% |
| 4. Debt/Equity 3.85 |
| 5. Debt/Ebitda 7.13 |
| 6. ROIC - WACC (= -2.65)% |
| 7. RoE -32.46% |
| 8. Rev. Trend -11.08% |
| 9. EPS Trend -25.86% |
What is the price of CMP shares?
Over the past week, the price has changed by +2.29%, over one month by +8.67%, over three months by +3.19% and over the past year by +84.88%.
Is CMP a buy, sell or hold?
- Strong Buy: 1
- Buy: 3
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CMP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 20.3 | 0.9% |
| Analysts Target Price | 20.3 | 0.9% |
| ValueRay Target Price | 19 | -5.5% |
CMP Fundamental Data Overview December 22, 2025
P/E Forward = 11.6009
P/S = 0.5415
P/B = 3.5031
P/EG = 0.1337
Beta = 1.571
Revenue TTM = 1.24b USD
EBIT TTM = 14.8m USD
EBITDA TTM = 118.0m USD
Long Term Debt = 832.2m USD (from longTermDebt, last quarter)
Short Term Debt = 30.5m USD (from shortTermDebt, last quarter)
Debt = 901.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 841.9m USD (from netDebt column, last quarter)
Enterprise Value = 1.66b USD (820.1m + Debt 901.6m - CCE 59.7m)
Interest Coverage Ratio = 0.22 (Ebit TTM 14.8m / Interest Expense TTM 68.5m)
FCF Yield = 7.70% (FCF TTM 128.0m / Enterprise Value 1.66b)
FCF Margin = 10.29% (FCF TTM 128.0m / Revenue TTM 1.24b)
Net Margin = -6.42% (Net Income TTM -79.8m / Revenue TTM 1.24b)
Gross Margin = 15.33% ((Revenue TTM 1.24b - Cost of Revenue TTM 1.05b) / Revenue TTM)
Gross Margin QoQ = 16.88% (prev 19.20%)
Tobins Q-Ratio = 1.08 (Enterprise Value 1.66b / Total Assets 1.54b)
Interest Expense / Debt = 1.92% (Interest Expense 17.3m / Debt 901.6m)
Taxrate = -80.0% (out of range, set to none) (3.20m / -4.00m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 2.15 (Total Current Assets 572.2m / Total Current Liabilities 265.6m)
Debt / Equity = 3.85 (Debt 901.6m / totalStockholderEquity, last quarter 234.1m)
Debt / EBITDA = 7.13 (Net Debt 841.9m / EBITDA 118.0m)
Debt / FCF = 6.58 (Net Debt 841.9m / FCF TTM 128.0m)
Total Stockholder Equity = 245.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -5.19% (Net Income -79.8m / Total Assets 1.54b)
RoE = -32.46% (Net Income TTM -79.8m / Total Stockholder Equity 245.8m)
RoCE = 1.37% (EBIT 14.8m / Capital Employed (Equity 245.8m + L.T.Debt 832.2m))
RoIC = 1.22% (EBIT 14.8m / (Assets 1.54b - Curr.Liab 265.6m - Cash 59.7m))
WACC = 3.87% (E(820.1m)/V(1.72b) * Re(8.12%) + (debt cost/tax rate unavailable))
Discount Rate = 8.12% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.98%
[DCF Debug] Terminal Value 70.14% ; FCFE base≈128.0m ; Y1≈84.0m ; Y5≈38.4m
Fair Price DCF = 17.84 (DCF Value 746.1m / Shares Outstanding 41.8m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -25.86 | EPS CAGR: -12.15% | SUE: 0.10 | # QB: 0
Revenue Correlation: -11.08 | Revenue CAGR: 1.94% | SUE: 0.13 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.59 | Chg30d=+0.141 | Revisions Net=+0 | Analysts=3
EPS current Year (2026-09-30): EPS=0.64 | Chg30d=-0.208 | Revisions Net=-1 | Growth EPS=+233.6% | Growth Revenue=-3.3%
EPS next Year (2027-09-30): EPS=0.94 | Chg30d=-0.164 | Revisions Net=-1 | Growth EPS=+46.9% | Growth Revenue=+4.3%
Additional Sources for CMP Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle